The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer

被引:0
|
作者
Gojnic, M [1 ]
Pervulov, M [1 ]
Petkovic, S [1 ]
Barisic, G [1 ]
Stojanovic, I [1 ]
Mostic, T [1 ]
Jeremic, K [1 ]
机构
[1] Fac Med Belgrade, Clin Ctr Serbia, Inst Gynecol & Obstet, Belgrade 11000, Serbia Monteneg
关键词
fallopian tube cancer; Doppler flow; amber extract;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
By following Doppler flow of the small pelvis with laboratory parameters and anamnesis data, we obtained more precise diagnostic possibilities for timely discovering of malignant processes in adnexal region and fallopian tube. By following patients who had come for routine check ups, prompted by a positive family history for malignant processes, resistant indexes of blood vessels in the adnexal region and vascularisation pattern were determined. Out of 78 women observed in the postmenopausal period with diagnosed adnexal masses, we found two cases of fallopian tube cancer. Resistance indexes ranged between 0.20 and 0.30 during a one-month period. Hystopathological analysis pointed to fallopian tube cancer. Besides Doppler flow, only patient history of amber extract use was significant. By CA125 market analysis, we found an increased value but not signifiant enough. Both patients had a positive family history according to the female hereditary line.
引用
收藏
页码:309 / 310
页数:2
相关论文
共 50 条
  • [41] Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer
    Lan, Chunyan
    Li, Yanfang
    Liu, Jihong
    GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 42 - 47
  • [42] Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
    Ghezelayagh, Talayeh S.
    Wu, Emily S.
    Barber, Emma L.
    Dao, Minh D.
    Zsiros, Emese
    Urban, Renata R.
    Gray, Heidi J.
    Goff, Barbara A.
    Shah, Chirag A.
    Neubauer, Nikki L.
    Dai, James Y.
    Tanyi, Janos L.
    Liao, John B.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (01) : 17 - 25
  • [43] Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999-2016: a retrospective study based on the Korean National Cancer Incidence Database
    Shin, Wonkyo
    Won, Young Joo
    Yoo, Chong Woo
    Lim, Jiwon
    Lim, Myong Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (04) : 1 - 9
  • [44] Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review
    Brockbank, E. C.
    Harry, V.
    Kolomainen, D.
    Mukhopadhyay, D.
    Sohaib, A.
    Bridges, J. E.
    Nobbenhuis, M. A. E.
    Shepherd, J. H.
    Ind, T. E. J.
    Barton, D. P. J.
    EJSO, 2013, 39 (08): : 912 - 917
  • [45] Synchronous primary endometrial and fallopian tube carcinoma with metchronous renal pelvis carcinoma in one patient: "Triple cancer- A rare occurrence "
    Gulati, Anchana
    Sharma, Reetika
    Sharma, Sudershan K.
    JOURNAL OF MID-LIFE HEALTH, 2022, 13 (03) : 244 - 246
  • [46] Cytoreduction of para-aortic lymph nodes behind the inferior vena cava and the right renal vessels in a patient with fallopian tube cancer
    Kato, Kazuyoshi
    Yamamoto, Akiko
    Takeshima, Nobuhiro
    GYNECOLOGIC ONCOLOGY, 2014, 134 (01) : 164 - 165
  • [47] Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
    Asare, Amma
    Previs, Rebecca Ann
    Spinosa, Daniel
    Fellman, Bryan
    Scott, Amelia L.
    Mulder, Isabelle
    Mahmoud, Y.
    Enbaya, Ahmed
    Siedel, Jean Hansen
    Cobb, Lauren
    Solima, Pamela T.
    Sood, Anil K.
    Coleman, Robert L.
    Secord, Angeles Alvarez
    Westin, Shannon N.
    GYNECOLOGIC ONCOLOGY, 2025, 194 : 112 - 118
  • [48] Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis
    Paley, PJ
    Swisher, EM
    Garcia, RL
    Agoff, SN
    Greer, BE
    Peters, KL
    Goff, BA
    GYNECOLOGIC ONCOLOGY, 2001, 80 (02) : 176 - 180
  • [49] Combined Weekly Topotecan and Biweekly Bevacizumab in Women With Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer Results of a Phase 2 Study
    McGonigle, Kathryn F.
    Muntz, Howard G.
    Vuky, Jacqueline
    Paley, Pamela J.
    Veljovich, Dan S.
    Greer, Benjamin E.
    Goff, Barbara A.
    Gray, Heidi J.
    Malpass, Thomas W.
    CANCER, 2011, 117 (16) : 3731 - 3740
  • [50] The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer
    Barcellini, Amelia
    Murata, Kazutoshi
    Fontana, Giulia
    Vai, Alessandro
    Cassani, Chiara
    Landoni, Fabio
    Locati, Laura Deborah
    Raspagliesi, Francesco
    Secondino, Simona
    Pecorilla, Mattia
    Yamada, Shigeru
    Okonogi, Noriyuki
    Orlandi, Ester
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 47